Peter Bergold

Dr. Peter Bergold is a Professor of Physiology and Pharmacology at SUNY-Downstate Health Sciences University. His research focuses on traumatic brain injury (TBI), neurodegeneration, and drug therapies targeting inflammation and neural repair. He has led the Graduate Program in Neural and Behavioral Sciences and has been recognized with the Chancellor’s Award for Teaching (2001). His work includes over 60 peer-reviewed publications and a U.S. patent on TBI treatment.

Education:

• PhD in Molecular Biology from Weill-Cornell Medical College (1986)
• Postdoctoral Fellowship in Neuroscience at Columbia University (1986-1990)

Research Interests:

• Pathophysiology and treatment of TBI, particularly chronic neurodegeneration post-injury
• Development of anti-inflammatory drug combinations (e.g., minocycline + N-acetylcysteine)
• Neuroprotection mechanisms and remyelination strategies

Grants & Awards:

• Funded by NIH and Department of Defense
• Served on NIH and DoD grant review panels for TBI/PTSD
• Chancellor’s Award in Teaching (2001)

Labs & Personnel:

• Led by Dr. Bergold, with postdoctoral fellow Dr. Elena Nikulina and graduate students Kristen Whitney and Karrah St. Laurent-Arriot
• Focus areas include TBI diagnosis, drug efficacy, and long-term outcomes